Loading clinical trials...
Loading clinical trials...
An Observational Study of Beta-Blocker Use in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Acute Myocardial Infarction
Conditions
Interventions
Observational
Locations
24
United States
University of Alabama at Birmingham
Birmingham, Alabama, United States
University of California, San Francisco-Fresno
Fresno, California, United States
LA BioMed at Harbor-UCLA Medical Center
Los Angeles, California, United States
University of California at San Francisco
San Francisco, California, United States
National Jewish Medical & Research Center
Denver, Colorado, United States
North Florida/South Georgia Veterans Health System
Gainesville, Florida, United States
Start Date
June 28, 2020
Primary Completion Date
May 18, 2022
Completion Date
December 2, 2022
Last Updated
January 31, 2025
NCT06712563
NCT07518472
NCT06831994
NCT05730088
NCT02755974
NCT07363980
Lead Sponsor
University of Minnesota
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions